Last reviewed · How we verify
Liposomal bupivacaine right injection — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Liposomal bupivacaine right injection (Liposomal bupivacaine right injection) — Prisma Health-Upstate.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Liposomal bupivacaine right injection TARGET | Liposomal bupivacaine right injection | Prisma Health-Upstate | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Liposomal bupivacaine right injection CI watch — RSS
- Liposomal bupivacaine right injection CI watch — Atom
- Liposomal bupivacaine right injection CI watch — JSON
- Liposomal bupivacaine right injection alone — RSS
Cite this brief
Drug Landscape (2026). Liposomal bupivacaine right injection — Competitive Intelligence Brief. https://druglandscape.com/ci/liposomal-bupivacaine-right-injection. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab